A Comparative Double Blind Trial of Pimozide and Fluphenazine in Chronic Schizophrenia

Publisher Website
Google Scholar
Abstract
Pimozide is a new neuroleptic drug and is chemically described as bis-para-fluoro-phenyl-butylpiperidine. It is active after oral administration, with a 24 hour duration of action and a peak effect lasting four to six hours (1). Superiority over placebo has been demonstrated by Brugmans (2).